Oncology Institute - TOIIW Competitors

Oncology Institute (NASDAQ:TOIIW) and P3 Health Partners (NASDAQ:PIIIW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, community ranking, institutional ownership, profitability, valuation, analyst recommendations and media sentiment.

Does the MarketBeat Community believe in TOIIW or PIIIW?

Oncology Institute and P3 Health Partners both received 0 outperform votes by MarketBeat users.

Company	Underperform	Outperform
Oncology Institute	N/A	N/A
P3 Health Partners	N/A	N/A

Is TOIIW or PIIIW more profitable?

Company	Net Margins	Return on Equity	Return on Assets
Oncology Institute	N/A	N/A	N/A
P3 Health Partners	N/A	N/A	N/A

Do analysts prefer TOIIW or PIIIW?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oncology Institute	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
P3 Health Partners	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Does the media prefer TOIIW or PIIIW?

In the previous week, P3 Health Partners had 1 more articles in the media than Oncology Institute. MarketBeat recorded 2 mentions for P3 Health Partners and 1 mentions for Oncology Institute. Oncology Institute's average media sentiment score of 1.87 beat P3 Health Partners' score of 1.43 indicating that Oncology Institute is being referred to more favorably in the media.

Company	Overall Sentiment
Oncology Institute	Very Positive
P3 Health Partners	Positive

Which has stronger valuation and earnings, TOIIW or PIIIW?

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oncology Institute	$252.48 million	N/A	N/A	N/A	N/A
P3 Health Partners	$556.70 million	N/A	N/A	N/A	N/A

Summary

P3 Health Partners beats Oncology Institute on 2 of the 3 factors compared between the two stocks.